Src blockage by siRNA inhibits VEGF-induced vascular hyperpemeability and osteoclast activity - an in vitro mechanism study for preventing destructive repair of osteonecrosis

被引:25
作者
Cao, Hui-Juan [1 ,3 ]
Zheng, Li-Zhen [2 ]
Wang, Nan [1 ,3 ]
Wang, Lin-Ying [1 ,3 ,4 ]
Li, Ye [1 ,3 ]
Li, Dan [1 ,3 ]
Lai, Yu-Xiao [1 ,3 ]
Wang, Xin-Luan [1 ,2 ,3 ]
Qjn, Ling [1 ,2 ,3 ]
机构
[1] Chinese Acad Sci, Translat Med R&D Ctr, Inst Biomed & Hlth Engn, Shenzhen Inst Adv Technol, Shenzhen, Peoples R China
[2] Chinese Univ Hong Kong, Musculoskeletal Res Lab, Dept Orthopaed & Traumatol, Hong Kong, Hong Kong, Peoples R China
[3] Shenzhen Bioact Mat Engn Lab Med, Shenzhen, Peoples R China
[4] Univ Sci & Technol China, Nano Sci & Technol Inst, Suzhou, Peoples R China
基金
美国国家科学基金会;
关键词
Destructive repair; Osteonecrosis; VEGF; c-Src; Vascular permeability; Osteoclasts activity; ENDOTHELIAL GROWTH-FACTOR; HUMAN FEMORAL-HEAD; C-SRC; BONE-RESORPTION; KINASE-ACTIVITY; CLINICAL-IMPLICATIONS; DIFFERENTIATION; PHOSPHORYLATION; ANGIOGENESIS; PERMEABILITY;
D O I
10.1016/j.bone.2014.12.060
中图分类号
R5 [内科学];
学科分类号
100201 [内科学];
摘要
Introduction: Destructive repair is the pathological feature of ONFH characterized with the elevated vascular permeability and persistent bone resorption, which is associated with higher VEGF expression, activated c-Src, and vascular leakage. Activated c-Src also participates in mediating endothelial permeability and osteoclasts activity. However, the molecular mechanism of the VEGF and c-Src contributing to the destructive repair process remains unknown. The purpose of this study is to delineate the role of VEGF and c-Src in triggering destructive repair of osteonecrosis in vitro, as well as to elucidate if VEGF mediating vascular permeability and osteoclastic bone resorption are Src dependent. Methods: We employed pharmacological VEGF to induce higher endothelial permeability and osteoclasts activity for simulating related pathological features of destructive repair in vitro. Src specific pp60(c-src)siRNA was used for determining the contribution of VEGF and Src to destructive repair. The primary endothelial cells and osteoclasts were treated with 50 ng/ml VEGF and/or transfected with the pp60(c-src)siRNA, while equivalent PBS and non-targeting siRNA were treated in the control groups. Results: VEGF enhanced Src bioactivity through promoting dephosphorylation of Src at Y527 and phosphorylation of Src at Y416. Meanwhile, Src specific pp60(c-src)siRNA significantly reduced Src expression in both cells. VEGF destroyed the junctional integrity of endothelial cells resulting in higher endothelial permeability. However, Src blockade significantly relieved VEGF induced actin stress and inhibited caveolae and VVOs formation, meanwhile further stabilized the complex beta-catenin/VE-cadherin/Flk-1 through decreasing phosphorylation of VE-cadherin, ultimately decreasing VEGF-mediating higher vascular permeability. In addition, VEGF promoted osteoclasts formation and function without affecting the adhesion activity and cytoskeleton. We further found that Src blockade significantly impaired cytoskeleton resulting in a lower adhesion activity through down-regulation of phosphorylation of Src, Pyla and Cbl, and ultimately inhibited osteoclasts formation and function. Conclusions: These findings provide a new insight into VEGF and c-Src mode of reaction in triggering destructive repair of osteonecrosis and further indicate that VEGF mediating vascular permeability and osteodasts activity are Src-dependent. Blockade of Src may have great potential as an effective therapy targeting destructive repair in osteonecrosis. (c) 2014 Elsevier Inc. All rights reserved.
引用
收藏
页码:58 / 68
页数:11
相关论文
共 41 条
[1]
Silencing of RB1 but not of RB2/P130 induces cellular senescence and impairs the differentiation potential of human mesenchymal stem cells [J].
Alessio, Nicola ;
Bohn, Wolfgang ;
Rauchberger, Verena ;
Rizzolio, Flavio ;
Cipollaro, Marilena ;
Rosemann, Michael ;
Irmler, Martin ;
Beckers, Johannes ;
Giordano, Antonio ;
Galderisi, Umberto .
CELLULAR AND MOLECULAR LIFE SCIENCES, 2013, 70 (09) :1637-1651
[2]
Vascular endothelial growth factors and vascular permeability [J].
Bates, David O. .
CARDIOVASCULAR RESEARCH, 2010, 87 (02) :262-271
[3]
LOSS OF EPITHELIAL DIFFERENTIATION AND GAIN OF INVASIVENESS CORRELATES WITH TYROSINE PHOSPHORYLATION OF THE E-CADHERIN BETA-CATENIN COMPLEX IN CELLS TRANSFORMED WITH A TEMPERATURE-SENSITIVE V-SRC GENE [J].
BEHRENS, J ;
VAKAET, L ;
FRIIS, R ;
WINTERHAGER, E ;
VANROY, F ;
MAREEL, MM ;
BIRCHMEIER, W .
JOURNAL OF CELL BIOLOGY, 1993, 120 (03) :757-766
[4]
Src Kinase becomes preferentially associated with the VEGFR, KDR/Flk-1, following VEGF stimulation of vascular endothelial cells [J].
Chou, Mary T. ;
Wang, Jing ;
Fujita, Donald J. .
BMC BIOCHEMISTRY, 2002, 3 :1-11
[5]
The tyrosine kinase activity of c-Src regulates actin dynamics and organization of podosomes in Osteoclasts [J].
Destaing, Olivier ;
Sanjay, Archana ;
Itzstein, Cecile ;
Horne, William C. ;
Toomre, Derek ;
De Camilli, Pietro ;
Baron, Roland .
MOLECULAR BIOLOGY OF THE CELL, 2008, 19 (01) :394-404
[6]
Src-mediated coupling of focal adhesion kinase to integrin αvβ5 in vascular endothelial growth factor signaling [J].
Eliceiri, BP ;
Puente, XS ;
Hood, JD ;
Stupack, DG ;
Schlaepfer, DD ;
Huang, XZZ ;
Sheppard, D ;
Cheresh, DA .
JOURNAL OF CELL BIOLOGY, 2002, 157 (01) :149-159
[7]
Matrix metalloproteinase 9 and vascular endothelial growth factor are essential for osteoclast recruitment into developing long bones [J].
Engsig, MT ;
Chen, QJ ;
Vu, TH ;
Pedersen, AC ;
Therkidsen, B ;
Lund, LR ;
Henriksen, K ;
Lenhard, T ;
Foged, NT ;
Werb, Z ;
Delaisse, JM .
JOURNAL OF CELL BIOLOGY, 2000, 151 (04) :879-889
[8]
Quantitative assay of senescence-associated β-galactosidase activity in mammalian cell extracts [J].
Gary, RK ;
Kindell, SM .
ANALYTICAL BIOCHEMISTRY, 2005, 343 (02) :329-334
[9]
VEGF couples hypertrophic cartilage remodeling, ossification and angiogenesis during endochondral bone formation [J].
Gerber, HP ;
Vu, TH ;
Ryan, AM ;
Kowalski, J ;
Werb, Z ;
Ferrara, N .
NATURE MEDICINE, 1999, 5 (06) :623-628
[10]
GLIMCHER MJ, 1979, CLIN ORTHOP RELAT R, P273